The company is commercialising novel Car T-cell therapy developed in New Zealand for cancer and other patients.
Assessing the impact of GDPR seven months on.
The online education platform wants to expand into new markets.
If confirmed, Spark New Zealand’s shareholding will be diluted to approximately 37.5%.
Why did an Aussie company pay a hefty sum for the business?
Hellman & Friedman backs off on Trade Me bidding war.
The industry doesn't need money or deregulation, it needs a government willing to engage with it, the report says.
Most staff were laid off today.
Entrepreneur Series: Co-founder Brooke Roberts says she's had no trouble attracting investment.
Automation takes the robot out of the human, so why would you want to put the human into the robot?